메뉴 건너뛰기




Volumn 33, Issue 1, 2016, Pages 182-184

Synbiotic supplementation promotes improvement of chronic diarrhea of unknown etiology in patient with chronic kidney disease and provides better outcomes in dialysis;La suplementación con simbióticos promueve la mejora de la diarrea crónica de etiología desconocida en pacientes con enfermedad renal crónica y ofrece mejores resultados en diálisis

Author keywords

Chronic kidney disease; Diarrhea; Hemodialysis; Microbiota; Synbiotics

Indexed keywords

SYNBIOTIC AGENT;

EID: 84981294562     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (20)
  • 1
    • 84891524250 scopus 로고    scopus 로고
    • Assessing the human gut microbiota in metabolic diseases
    • Karlsson F, Tremaroli V, Nielsen J, Bäckhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes 2013;62(10):3341-9.
    • (2013) Diabetes , vol.62 , Issue.10 , pp. 3341-3349
    • Karlsson, F.1    Tremaroli, V.2    Nielsen, J.3    Bäckhed, F.4
  • 2
    • 84873406524 scopus 로고    scopus 로고
    • Chronic kidney disease alters intestinal microbial flora
    • Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013;83(2):308-15.
    • (2013) Kidney Int , vol.83 , Issue.2 , pp. 308-315
    • Vaziri, N.D.1    Wong, J.2    Pahl, M.3
  • 3
    • 84927757224 scopus 로고    scopus 로고
    • Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?
    • Barros AF, Borges NA, Ferreira DC, et al. Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients? Future Microbiol (Print); 2015.
    • (2015) Future Microbiol (Print)
    • Barros, A.F.1    Borges, N.A.2    Ferreira, D.C.3
  • 5
    • 84899527145 scopus 로고    scopus 로고
    • Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease
    • Mafra D, Lobo JC, Barros AF, Koppe L, Vaziri ND, Fouque D. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol 2014;9(3):399-410.
    • (2014) Future Microbiol , vol.9 , Issue.3 , pp. 399-410
    • Mafra, D.1    Lobo, J.C.2    Barros, A.F.3    Koppe, L.4    Vaziri, N.D.5    Fouque, D.6
  • 6
    • 84867349985 scopus 로고    scopus 로고
    • Probiotics, prebiotics, and synbiotics: Gut and beyond
    • Vyas U, Ranganathan N. Probiotics, prebiotics, and synbiotics: Gut and beyond. Gastroenterol Res Pract 2012;16.
    • (2012) Gastroenterol Res Pract , pp. 16
    • Vyas, U.1    Ranganathan, N.2
  • 8
    • 12744273405 scopus 로고    scopus 로고
    • Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics
    • Gibson GR, Probert HM, Van Loo JAE, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004;17(2):259-75.
    • (2004) Nutr Res Rev , vol.17 , Issue.2 , pp. 259-275
    • Gibson, G.R.1    Probert, H.M.2    Van Loo, J.A.E.3    Rastall, R.A.4    Roberfroid, M.B.5
  • 9
    • 67649823905 scopus 로고    scopus 로고
    • Prevention of postoperative microbial infection by synbiotics
    • Nomoto K. Prevention of postoperative microbial infection by synbiotics. Indian J Exp Biol 2008;46(8):557-61.
    • (2008) Indian J Exp Biol , vol.46 , Issue.8 , pp. 557-561
    • Nomoto, K.1
  • 10
    • 84873100864 scopus 로고    scopus 로고
    • Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective
    • Shimizu K, Ogura H, Asahara T, et al. Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Dig Dis Sci 2013;58(1):23-32.
    • (2013) Dig Dis Sci , vol.58 , Issue.1 , pp. 23-32
    • Shimizu, K.1    Ogura, H.2    Asahara, T.3
  • 11
    • 79952176810 scopus 로고    scopus 로고
    • Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: A preliminary study
    • Nakabayashi I, Nakamura M, Kawakami K, et al. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant 2011;26(3):1094-8.
    • (2011) Nephrol Dial Transplant , vol.26 , Issue.3 , pp. 1094-1098
    • Nakabayashi, I.1    Nakamura, M.2    Kawakami, K.3
  • 12
    • 84929045778 scopus 로고    scopus 로고
    • Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial
    • Guida B, Germanò R, Trio R, et al. Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial. Nutr Metab Cardiovasc Dis 2014;24(9):1043-9.
    • (2014) Nutr Metab Cardiovasc Dis , vol.24 , Issue.9 , pp. 1043-1049
    • Guida, B.1    Germanò, R.2    Trio, R.3
  • 13
    • 84925883568 scopus 로고    scopus 로고
    • SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): A protocol of placebo-controlled randomised cross-over trial
    • Rossi M, Johnson DW, Morrison M, et al. SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial. BMC Nephrol 2014;15:106.
    • (2014) BMC Nephrol , vol.15 , pp. 106
    • Rossi, M.1    Johnson, D.W.2    Morrison, M.3
  • 14
    • 84909590764 scopus 로고    scopus 로고
    • Gastrointestinal symptoms: A comparison between patients undergoing peritoneal dialysis and hemodialysis
    • Dong R, Guo ZY, Ding JR, Zhou YY, Wu H. Gastrointestinal symptoms: A comparison between patients undergoing peritoneal dialysis and hemodialysis. World J Gastroenterol 2014;20(32):11370-5.
    • (2014) World J Gastroenterol , vol.20 , Issue.32 , pp. 11370-11375
    • Dong, R.1    Guo, Z.Y.2    Ding, J.R.3    Zhou, Y.Y.4    Wu, H.5
  • 15
    • 0035993278 scopus 로고    scopus 로고
    • The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well being
    • Strid H, Simrén M, Johansson AC, Svedlund J, Samuelsson O, Björnsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well being. Nephrol Dial Transplant 2002;17(8):1434-9.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.8 , pp. 1434-1439
    • Strid, H.1    Simrén, M.2    Johansson, A.C.3    Svedlund, J.4    Samuelsson, O.5    Björnsson, E.S.6
  • 16
    • 84887130474 scopus 로고    scopus 로고
    • Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine
    • Savignac HM, Corona G, Mills H, et al. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine. Neurochem Int 2013;63(8):756-64.
    • (2013) Neurochem Int , vol.63 , Issue.8 , pp. 756-764
    • Savignac, H.M.1    Corona, G.2    Mills, H.3
  • 17
    • 80052965474 scopus 로고    scopus 로고
    • Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
    • Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108(38):16050-5.
    • (2011) Proc Natl Acad Sci USA , vol.108 , Issue.38 , pp. 16050-16055
    • Bravo, J.A.1    Forsythe, P.2    Chew, M.V.3
  • 18
    • 77956218438 scopus 로고    scopus 로고
    • Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease
    • Ranganathan N, Ranganathan P, Friedman EA, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 2010;27(9):634-47.
    • (2010) Adv Ther , vol.27 , Issue.9 , pp. 634-647
    • Ranganathan, N.1    Ranganathan, P.2    Friedman, E.A.3
  • 19
    • 84901444529 scopus 로고    scopus 로고
    • The gut microbiome, kidney disease and targeted interventions
    • Ramezani A, Raj DS. The gut microbiome, kidney disease and targeted interventions. J Am Soc Nephrol 2014;25(4):657-70.
    • (2014) J Am Soc Nephrol , vol.25 , Issue.4 , pp. 657-670
    • Ramezani, A.1    Raj, D.S.2
  • 20
    • 39749160044 scopus 로고    scopus 로고
    • Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects
    • De Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K. Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects. Aliment Pharmacol Ther 2007;27(6):504-13.
    • (2007) Aliment Pharmacol Ther , vol.27 , Issue.6 , pp. 504-513
    • De Preter, V.1    Vanhoutte, T.2    Huys, G.3    Swings, J.4    Rutgeerts, P.5    Verbeke, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.